GENEVA -- As the race for a COVID-19 vaccine heats up, the World Health Organization is looking to limit the drug patents of the eventual developer to give all countries equal access -- an idea that does not sit well with the U.S., whose drugmakers are betting big on a potential cash cow.
The WHO on Tuesday adopted a resolution promising international cooperation to provide vaccines at affordable prices by limiting patents. The nonbinding resolution was proposed by members including Japan and the European Union, but the U.S. was not one of them.
